Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

2.

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, Herndier B, Northfelt DW, Huang J, Tulpule A, Levine AM.

N Engl J Med. 1997 Jun 5;336(23):1641-8.

3.
4.

Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.

Gordon LI, Andersen J, Colgan J, Glick J, Resnick GD, O'Connell M, Cassileth PA.

Cancer. 1995 Feb 1;75(3):865-73.

5.

Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma.

Walsh C, Wernz JC, Levine A, Rarick M, Willson E, Melendez D, Bonnem E, Thompson J, Shelton B.

J Acquir Immune Defic Syndr. 1993 Mar;6(3):265-71.

PMID:
7680712
6.
7.

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr, Miller TP.

N Engl J Med. 1993 Apr 8;328(14):1002-6.

8.

Interventions for previously untreated patients with AIDS-associated non-Hodgkin's lymphoma.

Martí-Carvajal AJ, Cardona AF, Lawrence A.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD005419. doi: 10.1002/14651858.CD005419.pub2. Review.

PMID:
19588373
10.

Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.

Shapiro CL, Yeap BY, Godleski J, Jochelson MS, Shipp MA, Skarin AT, Canellos GP.

Cancer. 1991 Aug 15;68(4):699-705.

11.

Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.

Tilly H, Mounier N, Lederlin P, Brière J, Dupriez B, Sebban C, Bosly A, Biron P, Nouvel C, Herbrecht R, Bordessoule D, Coiffier B.

J Clin Oncol. 2000 Mar;18(6):1309-15.

PMID:
10715302
12.
13.

Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.

Waits TM, Greco FA, Greer JP, Johnson DH, Wolff SN, Stein RS, McMaster ML, Hainsworth JD.

J Clin Oncol. 1993 May;11(5):943-9.

PMID:
7683712
14.

Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphoma.

Gabarre J, Lepage E, Thyss A, Tubiana R, Bastion Y, Schlaifer D, Sebban C, Ribrag V, Fereres M, Raphael M, et al.

Ann Oncol. 1995 Dec;6(10):1025-32.

PMID:
8750156
15.

The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.

Shipp MA, Yeap BY, Harrington DP, Klatt MM, Pinkus GS, Jochelson MS, Rosenthal DS, Skarin AT, Canellos GP.

J Clin Oncol. 1990 Jan;8(1):84-93.

PMID:
1688615
16.

A phase III comparative trial of m-BACOD vs m-BNCOD in the treatment of stage II-IV diffuse non-Hodgkin's lymphomas.

Guglielmi C, Gherlinzoni F, Amadori S, Mazza P, Mantovani L, Lauria F, Martelli M, Zinzani PL, Greco V, Poletti G, et al.

Haematologica. 1989 Nov-Dec;74(6):563-9.

PMID:
2483401
17.

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.

Gisselbrecht C, Oksenhendler E, Tirelli U, Lepage E, Gabarre J, Farcet JP, Gastaldi R, Coiffier B, Thyss A, Raphael M, et al.

Am J Med. 1993 Aug;95(2):188-96.

PMID:
7689296
18.

Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial.

Levine AM, Wernz JC, Kaplan L, Rodman N, Cohen P, Metroka C, Bennett JM, Rarick MU, Walsh C, Kahn J, et al.

JAMA. 1991 Jul 3;266(1):84-8.

PMID:
1710673
19.
20.
Items per page

Supplemental Content

Support Center